Related Experiment Videos

Strategies to manage the post-MI patient with ventricular arrhythmias

B Weinberg1, D Zipes

  • 1Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis 46202.

Clinical Cardiology
|July 1, 1989
PubMed

Insights

Late ventricular arrhythmias after myocardial infarction are common. Aggressive treatment is recommended for symptomatic patients, while risk stratification for asymptomatic individuals requires further research.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Critical Care Medicine

Background:

  • Late ventricular arrhythmias frequently occur after acute myocardial infarction.
  • Current data do not support treating asymptomatic premature ventricular complexes or non-sustained ventricular tachycardia post-myocardial infarction.

Purpose of the Study:

  • To review the management of late ventricular arrhythmias following acute myocardial infarction.
  • To identify risk markers and treatment strategies for patients at risk of sudden cardiac death.

Main Methods:

  • Review of available data on post-myocardial infarction arrhythmias.
  • Evaluation of signal-averaged electrocardiograms, Holter monitoring, and left ventricular function as risk markers.
  • Assessment of treatment options including electrophysiologic testing, antiarrhythmic drugs, surgery, and implantable cardioverter-defibrillators.

Main Results:

  • Asymptomatic arrhythmias after myocardial infarction are generally not treated.
  • Signal-averaged electrocardiograms, Holter monitoring, and left ventricular function show potential for risk stratification.
  • Patients with sustained ventricular tachycardia or ventricular fibrillation survivors require aggressive management.

Conclusions:

  • No established treatment exists for high-risk asymptomatic patients post-myocardial infarction.
  • Aggressive treatment, including electrophysiologic testing and device implantation, is crucial for high-risk symptomatic patients.
  • Further research is needed to define optimal risk stratification and treatment for asymptomatic subsets.

Related Concept Videos